- Fee assured
- Verified this account
- Head & neck oncology
My clinical practice is almost entirely devoted to benign and malignant diseases of the head and neck. I am one of the few surgeons in the United Kingdom with expertise in Transoral Robotic Surgery and Transoral Laser Microsurgery for head and neck cancers. I have accrued the largest experience in Transoral Robotic Surgery in the UK. My research interests are primarily on the processes of care, decision making and functional outcomes in head and neck oncology. I have published over 170 papers, reviews and book chapters on head and neck oncology. I am chief investigator for the NIHR funded TUBE trial and contribute as co-investigator and principal investigator for several other national trials. Currently, I serve as Chairman of the research council for the British Association of Head and Neck Oncologists, and as member of the following national bodies: Head and Neck Cancer Clinical Studies Group of the National Cancer Research Institute, the Interventional Procedures Panel of the National Institute for Health Research and the ENT-UK Head & Neck Society and the Guidelines committee for the 2016 National Institute for Health and Care Excellence guidelines on Upper aerodigestive tract cancer. I have co-edited the fourth and fifth editions of the UK National Head and Neck Cancer Multidisciplinary Management Guidelines, and also co-edit the section on "Head and Neck Disease" for the forthcoming 8th edition of Scott-Brown's Otolaryngology, the leading multi-volume multi-author textbook in the specialty in the world, planned for publication in July 2018. I am an Associate Editor for Head and Neck, the top ranked journal in the field, Senior Reviews Editor for the Journal of Laryngology and Otology, one of the oldest journals in the field (est. 1887) and serve on the editorial board for the Annals of Otology, Rhinology & Laryngology.
Areas of interest
Head and neck surgery; Thyroid disorders / surgery; Salivary gland disorders/surgery; Neck lumps; Benign and malignant diseases of the voice box (larynx); Swallowing problems
- Yildiz Akdag
- Head and Neck Unit Royal Marsden Hospital Fulham Road London SW3 6JJ
- 020 7811 8007
Anaesthetists worked with (Bupa members, please ask your consultant whether your anaesthetist is fee-assured)
Current NHS consultant posts held
Vinidh Paleri MS FRCS(ORL-HNS)
Consultant Head & Neck and Thyroid Surgeon
The Royal Marsden Hospital, London
Professor of Head and Neck Surgery
The Institute of Cancer Research, London
Northern Institute for Cancer Research
My research interests are primarily on the processes of care, decision making and functional outcomes in head and neck oncology. I am chief investigator for the NIHR funded TUBE trial (£373,196) and principal investigator for several other head and neck cancer research trials in progress within Newcastle upon Tyne Hospitals.
English, Tamil, Malayalam
I have published over 170 papers, reviews and book chapters on head and neck oncology (http://www.ncbi.nlm.nih.gov/pubmed/?term=paleri+v). I have co-edited the fourth and fifth editions of the "National Head and Neck Cancer Multidisciplinary Management Guidelines" (https://entuk.org/professionals/publications) and "Atlas of ENT Infections". (http://www.clinicalpublishing.co.uk/Book.asp?ID=120)
Courses offered to GPs
Head and neck diseases
1. Outcomes for my transoral resection for vocal cord cancers at 3 yrs mean follow up: 90% all cause mortality, 100% cancer free survival
2. Summary Hospital-level Mortality Index for my practice Jul'12 to Jun'13 is 26 (vs 37 for peer group); readmission rate 3.5% (vs 4.6% for peer group).
3. Crude mortality for my high risk cancer practice is 0.3%, falling well within 2 standard deviations of national figures for all ENT procedures.
Reference number 5179619
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.